The influence of different concentration of proFLEX® INTRA on clinical progression and dynamics of laboratory test values in different age patients with knee osteoarthrosis

Authors

  • Stanislav Bondarenko Sytenko Institute of Spine and Joint Pathology National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine https://orcid.org/0000-0003-2463-5919
  • Frieda Leontyeva Sytenko Institute of Spine and Joint Pathology National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine
  • Dmytro Morozenko National University оf Pharmacy, Kharkiv. Ukraine, Ukraine

DOI:

https://doi.org/10.15674/0030-59872020261-67

Keywords:

knee osteoarthritis, blood biomarkers, synovial fluid, hyaluronic acid gel, intraarticular injection, aged patients

Abstract

Introduction: application of hyaluronic acid gel for intraarticular administration is actual topic of modern orthopaedic concerning to its therapeutical efficacy. Objective: to assess the influence of different concentrations of proFLEX® INTRA on the synovial fluid and biochemical blood markers in patients with the 2nd knee osteoarthritis stage in the different age groups. Materials and methods: 30 patients with Kellgren–Lawrence stage II knee osteoarthritis were examined. The first group consisted of 15 patients aged 40–50 years, in the second group the average age of patients was 50–70 years. Each group was divided into 3 subgroups (a, b, c) of 5 patients. In each group the first subgroup of patients received intra-articular 1 injection of proFLEX® INTRA 10 mg/ml 2.0 ml, І-b, ІІ-b — 12 mg/ml 2.5 ml, І-с, ІІ-с — 20 mg/ml 3.0 ml. Results: an inflammatory-dystrophic process in the knee joint of patients was found in both groups, which was more expressed in elderly patients. The dynamics of blood markers in patients of the 1st and 2nd groups after the treatment showed a decreasing the level of inflammatory and dystrophic processes in the knee joints. In the 1st group 1 month after intra-articular injection, the content of glycoproteins and chondroitin sulfates (CS) decreased, did not reach the normative values. In subgroup II-c the level of glycoproteins and CS decreased, the concentration of interleukin-6 (IL-6) remained elevated comparing to subgroups II-a and II-b. Conclusions: it was found that patients with stage II knee osteoarthritis had increased CS and lower levels of hyaluronic acid in their synovial fluid. Markers of inflammation (glycoproteins and IL-6) and destruction markers (CS) in the blood serum changed unidirectionally and indicated a decreasing in the activity of inflammatory process after the injection of hyaluronic acid gel, which was clinically confirmed 1 month after intra-articular injection. In this case, the results after the reexamination of blood biomarkers of patients aged 40–50 years indicated a higher efficiency of hyaluronic acid gel injection with a concentration of 10 and 12 mg/ml, aged 50–70 years — a concentration of 20 mg/ml was confirmed by a decrease in the level of glycoproteins, CS and IL-6 in the blood of patients.

Author Biographies

Stanislav Bondarenko, Sytenko Institute of Spine and Joint Pathology National Academy of Medical Sciences of Ukraine, Kharkiv

Doctor of Traumatology and Orthopaedics

Frieda Leontyeva, Sytenko Institute of Spine and Joint Pathology National Academy of Medical Sciences of Ukraine, Kharkiv

PhD in Biol. Sci.

Dmytro Morozenko, National University оf Pharmacy, Kharkiv. Ukraine

Doctor of Veter. Sci.

References

  1. Dai, W., Lin, Z., Guo, D., Shi, Z., & Wang, J. (2018). Efficacy and safety of Hylan versus Hyaluronic acid in the treatment of knee osteoarthritis. The Journal of Knee Surgery, 32(03), 259-268. doi: 10.1055/s-0038-1641142
  2. He, W., Kuang, M., Zhao, J., Sun, L., Lu, B., Wang, Y., … Ma, X. (2017). Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: A meta-analysis. International Journal of Surgery, 39, 95-103. doi: 10.1016/j.ijsu.2017.01.087
  3. Abate, M., Vanni, D., Pantalone, A., & Salini, V. (2015). Hyaluronic acid in knee osteoarthritis: Preliminary results using a four months administration schedule. International Journal of Rheumatic Diseases, 20(2), 199-202. doi: 10.1111/1756-185x.12572
  4. Vyrva, O. Ye., & Ashukina, N. O. (2018). Hyaluronic acid drugs in the treatment of pathology of the musculoskeletal system (literature review). Orthopedics, traumatology and prosthetics, 1(610), 117-124. doi: 10.15674/0030-598720181117-124. [in Ukrainian]
  5. Cooper, C., Rannou, F., & Richette, P. (2017). Use of intraarticular hyaluronic acid in the management of knee osteoarthritis in clinical practice. Arthritis Care & Research, 69(9), 1287-1296. doi: 10.1002/acr.23204
  6. Ong, K. L., Runa, M., Xiao, Z., Ngai, W., Lau, E., & Altman, R. D. (2020). Severe acute localized reactions following intra-articular Hyaluronic acid injections in knee osteoarthritis. CARTILAGE, 194760352090511. doi: 10.1177/1947603520905113
  7. Sirin, D., Kaplan, N., Yilmaz, I., Karaarslan, N., Ozbek, H., Akyuva, Y., … Mahirogullari, M. (2018). The association between different molecular weights of hyaluronic acid and CHAD, HIF-1α, COL2A1 expression in chondrocyte cultures. Experimental and Therapeutic Medicine. doi: 10.3892/etm.2018.5943
  8. Kamyshnikov, V. S. (2009). Handbook of clinical and biochemical studies in laboratory diagnostics. Moscow: Medpress-inform. [in Russian]
  9. Morozenko, D. V., & Leontieva, F. S. (2016). Methods of research of metabolic markers connective tissue in modern clinical and experimental medicine. Young scientist. 2(29), 168-172. [in Ukrainian]
  10. Petrie, A. (2019). Medical Statistics at a Glance (4th Edition). Wiley-Blackwell
  11. Maruschak, O. P. (2019). Diagnosis of early periprosthetic infection after knee and hip arthroplasty joints (clinical study): dissertation of PhD in Medical Sciences. Kharkiv. [in Ukrainian]
  12. Filipenko, V. A., Leontieva, F. S., Morozenko, D. V., & Korzh I. V. (2012). The content of cytokines in the serum of osteoarthritis. Orthopedics, traumatology and prosthetics, 3, 52-55. doi: 10.15674/0030-59872012352-55. [in Ukrainian]
  13. Miltner, O., Schneider, U., Siebert, C., Niedhart, C., & Niethard, F. (2002). Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis—a prospective clinical trial. Osteoarthritis and Cartilage, 10(9), 680-686. doi: 10.1053/joca.2002.0815
  14. Petrella, R. J., & Petrella, M. (2006). Prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. The Journal of Rheumatology, 33, 951-956
  15. Bannuru, R., Natov, N., Dasi, U., Schmid, C., & McAlindon, T. (2011). Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis – meta-analysis. Osteoarthritis and Cartilage, 19(6), 611-619. doi: 10.1016/j.joca.2010.09.014
  16. Rutjes, A. W., Jüni, P., da Costa, B. R., Trelle, S., Nüesch, E., & Reichenbach, S. (2012). Viscosupplementation for osteoarthritis of the knee. Annals of Internal Medicine, 157(3), 180. doi: 10.7326/0003-4819-157-3-201208070-00473
  17. Sun, S., Hsu, C., Hwang, C., Hsu, P., Wang, J., Tsai, S., … Wang, Y. (2006). Hyaluronate improves pain, physical function and balance in the geriatric osteoarthritic knee: A 6-month follow-up study using clinical tests. Osteoarthritis and Cartilage, 14(7), 696-701. doi: 10.1016/j.joca.2006.01.010
  18. Gigis, I., Fotiadis, E., Nenopoulos, A., Tsitas, K., & Hatzokos, I. (2016). Comparison of two different molecular weight intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis. Hippokratia, 20(1), 26-31
  19. Uçar, D., Dıraçoğlu, D., Süleyman, T., & Çapan, N. (2013). Intra-articular hyaluronic acid as treatment in elderly and middle-aged patients with knee osteoarthritis. The Open Rheumatology Journal, 7(1), 38-41. doi: 10.2174/1874312901307010038

Downloads

How to Cite

Bondarenko, S., Leontyeva, F., & Morozenko, D. (2023). The influence of different concentration of proFLEX® INTRA on clinical progression and dynamics of laboratory test values in different age patients with knee osteoarthrosis. ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (2), 61–67. https://doi.org/10.15674/0030-59872020261-67

Issue

No. 2 (2020)

Section

ORIGINAL ARTICLES

License

Copyright (c) 2020 Stanislav Bondarenko, Frieda Leontyeva, Dmytro Morozenko

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).